¼¼°èÀÇ ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀå : ±âȸ ¹× Àü·«(-2033³â)
Molecular Diagnostics Devices And Equipment Global Market Opportunities And Strategies To 2033
»óǰÄÚµå : 1596064
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 346 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 6,850,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,275,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,701,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀåÀº 2018³â 68¾ï 3,097¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2023³â±îÁö ¿¬Æò±Õ 20.00% ÀÌ»ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°¨¿°º´ÀÇ ³ôÀº À¯º´·ü

°¨¿°º´ÀÇ ³ôÀº À¯ÇàÀº Áö³­ ±â°£ µ¿¾È ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇßÀ¸¸ç, HIV, °áÇÙ, µ¶°¨, ±×¸®°í ÃÖ±Ù¿¡´Â Äڷγª19¿Í °°Àº Àü¿°º´ Áõ°¡´Â Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄ×½À´Ï´Ù. ºÐÀÚÁø´Ü Àåºñ¿Í ±â±â´Â Á¶±â ¹ß°ß, ¸ð´ÏÅ͸µ, Ä¡·á ¹æÄ§ °áÁ¤¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ë·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ ±¹Á¦ ºñÁ¤ºÎ±â±¸ÀÎ ¼¼°è°æÁ¦Æ÷·³(World Economic Forum)¿¡ µû¸£¸é, 2023³â¿¡´Â Äڷγª19 ÀÌÈÄ µ¶°¨, È£Èí±â¼¼Æ÷À¶ÇÕ¹ÙÀÌ·¯½º(RSV) µî °¨¿°¼º ÁúȯÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â 2023³â 2¿ù ±âÁØ µ¶°¨À¸·Î ÀÎÇÑ ÃßÁ¤ ȯÀÚ ¼ö´Â 2,400¸¸ ¸í, ÀÔ¿ø ȯÀÚ ¼ö´Â 26¸¸ ¸í, »ç¸ÁÀÚ ¼ö´Â 1¸¸ 6,000¸í¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2022³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 1,060¸¸ ¸íÀÌ °áÇÙ¿¡ °¨¿°µÇ°í 130¸¸ ¸íÀÌ °áÇÙÀ¸·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ °¨¿°¼º ÁúȯÀÇ ³ôÀº À¯ÇàÀÌ ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀåÀ» °ßÀÎÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå Ç¥ ¸®½ºÆ®

Á¦4Àå ±×·¡ÇÁ ¸®½ºÆ®

Á¦5Àå º¸°í¼­ ±¸¼º

Á¦6Àå ½ÃÀå Æ¯Â¡

Á¦7Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦8Àå ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦9Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦10Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀå : ¼¼ºÐÈ­

Á¦11Àå ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀå : Áö¿ª¡¤±¹°¡º° ºÐ¼®

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦13Àå ¼­À¯·´ ½ÃÀå

Á¦14Àå µ¿À¯·´ ½ÃÀå

Á¦15Àå ºÏ¹Ì ½ÃÀå

Á¦16Àå ³²¹Ì ½ÃÀå

Á¦17Àå Áßµ¿ ½ÃÀå

Á¦18Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦19Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦20Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦21Àå °æÀï º¥Ä¡¸¶Å·

Á¦22Àå °æÀï ´ë½Ãº¸µå

Á¦23Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦24Àå ±âȸ¿Í Àü·«

Á¦25Àå ºÐÀÚÁø´Ü ±â±â ¹× Àåºñ ½ÃÀå : °á·Ð°ú Á¦¾È

Á¦26Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Molecular diagnostics devices and equipment refer to tools that are used to detect and analyze biological markers in the genome and proteome. These devices help identify diseases, infections and genetic conditions by analyzing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins. They are essential for diagnosing conditions such as cancer, infectious diseases, genetic disorders and other conditions, offering more accurate and rapid results than traditional methods.

The molecular diagnostics devices and equipment market consists of sales, by entities (organizations, sole traders and partnerships), of molecular diagnostics devices and equipment that are used to diagnose diseases and perform screening by detecting specific sequences in DNA, RNA and proteins at a molecular level.

The global molecular diagnostics devices and equipment market was valued at $6,830.97 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.

High Prevalence Of Infectious Diseases

The high prevalence of infectious diseases supported the growth of the molecular diagnostics devices and equipment market during the historic period. The increasing prevalence of infectious diseases such as HIV, tuberculosis, influenza and most recently, COVID-19, has significantly heightened the demand for accurate and timely diagnostic solutions. The molecular diagnostics devices and equipment became essential for early detection, monitoring and treatment decisions, leading to higher investments in research and development. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the World Health Organization, 10.6 million people were infected with tuberculosis globally, with 1.3 million deaths attributed to tuberculosis. Therefore, high prevalence of infectious diseases drove the molecular diagnostics devices and equipment market.

Focus On Next-Generation qPCR Systems To Enhance Usability And Custom Test Development

Companies operating in the molecular diagnostics devices and equipment market are developing next-generation quantitative polymerase chain reaction (qPCR) systems to enhance usability and custom test development. These next-generation qPCR systems are designed to enhance usability and support custom test development, addressing the growing clinical needs and public health challenges. For example, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced its next-generation qPCR system, the LightCycler PRO System, designed to meet the evolving clinical needs in molecular diagnostics and address public health challenges. This advanced system enhances performance and usability, enabling healthcare professionals to seamlessly transition between research and clinical applications. It supports the development of custom tests and includes a comprehensive portfolio of over 200 research assays and more than 60 Conformite Europeenne In-Vitro Diagnostic (CE-IVD) assays.

The global molecular diagnostics devices and equipment market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 73.25% of the total market in 2023.

Molecular Diagnostics Devices And Equipment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global molecular diagnostics devices and equipment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for molecular diagnostics devices and equipment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The molecular diagnostics devices and equipment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider molecular diagnostics devices and equipment market; and compares it with other markets.

The report covers the following chapters

Markets Covered:

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Major Market Trends

8 Molecular Diagnostics Devices And Equipment Market - Macro-Economic Scenario

9 Global Market Size And Growth

10 Global Molecular Diagnostics Devices And Equipment Market Segmentation

11 Molecular Diagnostics Devices And Equipment Market, Regional and Country Analysis

12 Asia-Pacific Market

13 Western Europe Market

14 Eastern Europe Market

15 North America Market

16 South America Market

17 Middle East Market

18 Africa Market

19 Competitive Landscape And Company Profiles

20 Other Major And Innovative Companies

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

24 Opportunities And Strategies

25 Molecular Diagnostics Devices And Equipment Market, Conclusions And Recommendations

26 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â